Retrospective analysis of aeromonas infections reveals high resistance patterns in patients, highlighting the need for careful antibiotic management.
Abstract Aeromonas species are emerging human pathogens causing diverse infections. We retrospectively reviewed 61 culture-proven cases (2019–2025) at a tertiary centre in South India. Mean patient age was 46 years; 57% were male. Skin and soft tissue infections (40.9%) and bacteremia (40.9%) were predominant, with pulmonary and urinary infections less common. Comorbidities included diabetes (27.8%) and liver disease (14.7%); trauma preceded 16.3% of cases. Carbapenem resistance was high (meropenem 54.7%, imipenem 27.8%), though cephalosporins retained activity. Most patients recovered (81.9%), while mortality was 13.1%. Findings emphasize diagnostic vigilance and rational antibiotic use in Aeromonas infections.
No takes yet. Share an insight, caveat, or question.
M et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: